Business
Telix (ASX:TLX) share price lower despite key FDA update
Image source: Getty Images
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is edging lower on Thursday morning despite the release of a positive announcement.
At the time of writing, the biopharmaceuticals company’s shares are down slightly to $5.61.
What did Telix…
Continue Reading
-
General24 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Business24 hours agoWhy this ASX 200 stock could deliver a 30% return
-
Noosa News23 hours agoWoman charged with Mark Akers’s murder after body found on roadside
-
Noosa News24 hours agoWhere to Watch Live Music in Brisbane